712 related articles for article (PubMed ID: 12894246)
1. The emerging role of lysophosphatidic acid in cancer.
Mills GB; Moolenaar WH
Nat Rev Cancer; 2003 Aug; 3(8):582-91. PubMed ID: 12894246
[TBL] [Abstract][Full Text] [Related]
2. Bioactive lysophospholipids and their G protein-coupled receptors.
Moolenaar WH
Exp Cell Res; 1999 Nov; 253(1):230-8. PubMed ID: 10579925
[TBL] [Abstract][Full Text] [Related]
3. The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer.
Tanyi JL; Morris AJ; Wolf JK; Fang X; Hasegawa Y; Lapushin R; Auersperg N; Sigal YJ; Newman RA; Felix EA; Atkinson EN; Mills GB
Cancer Res; 2003 Mar; 63(5):1073-82. PubMed ID: 12615725
[TBL] [Abstract][Full Text] [Related]
4. Lysophospholipids--receptor revelations.
Hla T; Lee MJ; Ancellin N; Paik JH; Kluk MJ
Science; 2001 Nov; 294(5548):1875-8. PubMed ID: 11729304
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid- and Gbeta-dependent activation of Dictyostelium MAP kinase ERK2.
Schenk PW; Epskamp SJ; Knetsch ML; Harten V; Lagendijk EL; van Duijn B; Snaar-Jagalska BE
Biochem Biophys Res Commun; 2001 Apr; 282(3):765-72. PubMed ID: 11401529
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK.
Stähle M; Veit C; Bachfischer U; Schierling K; Skripczynski B; Hall A; Gierschik P; Giehl K
J Cell Sci; 2003 Sep; 116(Pt 18):3835-46. PubMed ID: 12902401
[TBL] [Abstract][Full Text] [Related]
7. Mammalian PSP24s (alpha and beta isoforms) are not responsive to lysophosphatidic acid in mammalian expression systems.
Kawasawa Y; Kume K; Izumi T; Shimizu T
Biochem Biophys Res Commun; 2000 Oct; 276(3):957-64. PubMed ID: 11027575
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
Gueguen G; Gaigé B; Grévy JM; Rogalle P; Bellan J; Wilson M; Klaébé A; Pont F; Simon MF; Chap H
Biochemistry; 1999 Jun; 38(26):8440-50. PubMed ID: 10387090
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of migration-resistant hydroxyethoxy analogues of lysophosphatidic acid.
Qian L; Xu Y; Arai H; Aoki J; McIntyre TM; Prestwich GD
Org Lett; 2003 Nov; 5(24):4685-8. PubMed ID: 14627415
[TBL] [Abstract][Full Text] [Related]
10. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
[TBL] [Abstract][Full Text] [Related]
11. Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases.
Gendaszewska-Darmach E
Acta Biochim Pol; 2008; 55(2):227-40. PubMed ID: 18560605
[TBL] [Abstract][Full Text] [Related]
12. Structure--activity relationships of lysophosphatidic acid: conformationally restricted backbone mimetics.
Hopper DW; Ragan SP; Hooks SB; Lynch KR; Macdonald TL
J Med Chem; 1999 Mar; 42(6):963-70. PubMed ID: 10090779
[TBL] [Abstract][Full Text] [Related]
13. [Lysophosphatidic acid: a "bioactive" phospholipid].
Saulnier-Blache JS
Med Sci (Paris); 2004; 20(8-9):799-803. PubMed ID: 15361348
[TBL] [Abstract][Full Text] [Related]
14. Potential role of lysophosphatidic acid in hypertension and atherosclerosis.
Xu YJ; Aziz OA; Bhugra P; Arneja AS; Mendis MR; Dhalla NS
Can J Cardiol; 2003 Dec; 19(13):1525-36. PubMed ID: 14760444
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidic acid production and action: validated targets in cancer?
Umezu-Goto M; Tanyi J; Lahad J; Liu S; Yu S; Lapushin R; Hasegawa Y; Lu Y; Trost R; Bevers T; Jonasch E; Aldape K; Liu J; James RD; Ferguson CG; Xu Y; Prestwich GD; Mills GB
J Cell Biochem; 2004 Aug; 92(6):1115-40. PubMed ID: 15258897
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid regulates the proliferation and migration of olfactory ensheathing cells in vitro.
Yan H; Lu D; Rivkees SA
Glia; 2003 Oct; 44(1):26-36. PubMed ID: 12951654
[TBL] [Abstract][Full Text] [Related]
17. G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival.
Radeff-Huang J; Seasholtz TM; Matteo RG; Brown JH
J Cell Biochem; 2004 Aug; 92(5):949-66. PubMed ID: 15258918
[TBL] [Abstract][Full Text] [Related]
18. Beta-catenin, cancer, and G proteins: not just for frizzleds anymore.
Malbon CC
Sci STKE; 2005 Jul; 2005(292):pe35. PubMed ID: 16014605
[TBL] [Abstract][Full Text] [Related]
19. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
[TBL] [Abstract][Full Text] [Related]
20. Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes.
Sorensen SD; Nicole O; Peavy RD; Montoya LM; Lee CJ; Murphy TJ; Traynelis SF; Hepler JR
Mol Pharmacol; 2003 Nov; 64(5):1199-209. PubMed ID: 14573770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
